Frederic H. Moll

Frederic H. Moll, listed as board member, has filed trades across 6 companies (mainly through SEC (Form 4)), most often in Shockwave Medical, Inc., Intersect ENT, Inc. and PROCEPT BioRobotics Corp. In total, 49 filings cover trades dated from 29 February 2016 to 6 March 2026.

In open-market terms, that means 7 purchases worth €17.2M on one side and 11 sales worth €4.4M on the other. On balance, insiders were net buyers of €12.8M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 13 share grants and 5 option exercises. 2026 to date brings 1 purchase and no sales.

A typical purchase (the median) is worth €1.9M. On 6 out of 7 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.

Most recently, on 10 March 2026, the filings show an open-market purchase worth €1.7M in SS Innovations International, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.